Adenosine A2A receptor antagonist istradefylline for levodopa-induced complications in Parkinson's disease

To assess the efficacy and safety of adjuvant istradefylline therapy versus placebo in PD patients with levodopa-induced complications.

This is a protocol.

Share/Save